A detailed history of Howe & Rusling Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Howe & Rusling Inc holds 149,596 shares of AZN stock, worth $11.9 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
149,596
Previous 161,458 7.35%
Holding current value
$11.9 Million
Previous $10.9 Million 6.66%
% of portfolio
1.07%
Previous 1.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $792,500 - $958,805
-11,862 Reduced 7.35%
149,596 $11.7 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $302,830 - $345,206
4,962 Added 3.17%
161,458 $10.9 Million
Q4 2023

Feb 05, 2024

BUY
$61.89 - $69.28 $1.75 Million - $1.96 Million
28,282 Added 22.06%
156,496 $10.5 Million
Q3 2023

Nov 08, 2023

SELL
$64.85 - $71.7 $34,565 - $38,216
-533 Reduced 0.41%
128,214 $8.68 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $1.46 Million - $1.58 Million
-20,856 Reduced 13.94%
128,747 $9.21 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $159,201 - $180,503
2,521 Added 1.71%
149,603 $10.4 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $261,834 - $340,225
4,830 Added 3.4%
147,082 $9.97 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $3.81 Million - $9.75 Million
71,859 Added 102.08%
142,252 $7.8 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $4.17 Million - $5.01 Million
70,393 New
70,393 $4.65 Million
Q4 2020

Feb 08, 2021

SELL
$48.52 - $58.02 $5,337 - $6,382
-110 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$53.07 - $61.1 $5,837 - $6,721
110 New
110 $6,000
Q2 2019

Aug 12, 2019

SELL
$37.28 - $41.68 $10,587 - $11,837
-284 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$35.49 - $43.02 $10,079 - $12,217
284 New
284 $11,000
Q4 2017

Jan 24, 2018

SELL
$32.09 - $34.78 $55,130 - $59,752
-1,718 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$28.96 - $34.0 $49,753 - $58,412
1,718
1,718 $58,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.